Dicot is developing a modern potency drug that will treat erectile dysfunction and premature ejaculation better than existing drugs.
The development takes place under its own auspices up to and including phase 2 studies. Thereafter, Dicot’s intention is to enter into strategic alliances, or alternatively carry out a trade sale, with larger, established pharmaceutical companies in order to be able to introduce LIB-01 on the world market.
